Literature DB >> 16520856

Delivery of primary percutaneous coronary intervention for the management of acute ST segment elevation myocardial infarction: summary of the Cardiac Care Network of Ontario Consensus Report.

Marino Labinaz1, Terri Swabey, Randal Watson, Madhu Natarajan, Wendy Fucile, Bruce Lubelsky, Bruce Sawadsky, Eric Cohen, Kevin Glasgow.   

Abstract

Tremendous debate has developed over the efficacy of primary percutaneous coronary intervention (PCI) compared with fibrinolysis as the preferred treatment for acute ST segment elevation myocardial infarction (STEMI). In 2002, the Ontario Ministry of Heath and Long-Term Care commissioned the Cardiac Care Network of Ontario to develop consensus recommendations regarding the provincial coordination and provision of urgent PCI for STEMI patients. The panel's work has provided important insights into the acute treatment of STEMI that may be useful to other jurisdictions and may provide a reference for other regions considering the implementation of primary PCI for the management of STEMI patients in their community. In the present report, the evidence for primary PCI is reviewed, the important barriers to implementing this strategy are summarized and several recommendations and models of care for the delivery of primary PCI for STEMI on a wide scale are presented.

Entities:  

Mesh:

Year:  2006        PMID: 16520856      PMCID: PMC2528927          DOI: 10.1016/s0828-282x(06)70904-7

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  50 in total

1.  Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis.

Authors:  L J Morrison; P R Verbeek; A C McDonald; B V Sawadsky; D J Cook
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

Review 2.  Fibrinolytic therapy: is it a treatment of the past?

Authors:  Cindy L Grines; Patrick Serruys; William W O'Neill
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

Review 3.  Fibrinolysis for acute myocardial infarction: the future is here and now.

Authors:  Paul W Armstrong; Désiré Collen; Elliott Antman
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

Review 4.  Rising to the challenge: transforming the treatment of ST-segment elevation myocardial infarction.

Authors:  William A Ghali; Cameron R Donaldson; Merril L Knudtson; Steven J Lewis; Colleen J Maxwell; Jack V Tu
Journal:  CMAJ       Date:  2003-07-08       Impact factor: 8.262

Review 5.  Primary angioplasty for ST-segment elevation myocardial infarction: ready for prime time?

Authors:  Madhu K Natarajan; Salim Yusuf
Journal:  CMAJ       Date:  2003-07-08       Impact factor: 8.262

6.  The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators.

Authors:  J G Canto; N R Every; D J Magid; W J Rogers; J A Malmgren; P D Frederick; W J French; A J Tiefenbrunn; V K Misra; C I Kiefe; H V Barron
Journal:  N Engl J Med       Date:  2000-05-25       Impact factor: 91.245

7.  Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study.

Authors:  P Widimský; L Groch; M Zelízko; M Aschermann; F Bednár; H Suryapranata
Journal:  Eur Heart J       Date:  2000-05       Impact factor: 29.983

8.  Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years.

Authors:  D R Thiemann; J Coresh; S P Schulman; G Gerstenblith; W J Oetgen; N R Powe
Journal:  Circulation       Date:  2000-05-16       Impact factor: 29.690

9.  Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction.

Authors:  L Wallentin; P Goldstein; P W Armstrong; C B Granger; A A J Adgey; H R Arntz; K Bogaerts; T Danays; B Lindahl; M Mäkijärvi; F Verheugt; F Van de Werf
Journal:  Circulation       Date:  2003-07-07       Impact factor: 29.690

10.  A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction.

Authors:  Henning R Andersen; Torsten T Nielsen; Klaus Rasmussen; Leif Thuesen; Henning Kelbaek; Per Thayssen; Ulrik Abildgaard; Flemming Pedersen; Jan K Madsen; Peer Grande; Anton B Villadsen; Lars R Krusell; Torben Haghfelt; Preben Lomholt; Steen E Husted; Else Vigholt; Henrik K Kjaergard; Leif Spange Mortensen
Journal:  N Engl J Med       Date:  2003-08-21       Impact factor: 91.245

View more
  4 in total

1.  Prehospital evaluation and economic analysis of different coronary syndrome treatment strategies--PREDICT--rationale, development and implementation.

Authors:  Laurie J Morrison; Valeria E Rac; James M Bowen; Brian Schwartz; Tyrone Perreira; Welson Ryan; Cathy Zahn; Rishab Chadha; Alan Craig; Daria O'Reilly; Ron Goeree
Journal:  BMC Emerg Med       Date:  2011-03-29

2.  Regional "Call 911" Emergency Department Protocol to Reduce Interfacility Transfer Delay for Patients With ST-Segment-Elevation Myocardial Infarction.

Authors:  Nichole Bosson; Terrence Baruch; William J French; Andrea Fang; Amy H Kaji; Marianne Gausche-Hill; Alisa Rock; David Shavelle; Joseph L Thomas; James T Niemann
Journal:  J Am Heart Assoc       Date:  2017-12-23       Impact factor: 5.501

3.  Retrograde CTO-PCI Using an Internal Thoracic Bypass Graft Segment in a Patient with Acute Inferior ST-Elevation Myocardial Infarction and Cardiogenic Shock.

Authors:  Claudiu Ungureanu; Giuseppe Colletti; Marc Blaimont; Alexandre Avran
Journal:  Int Med Case Rep J       Date:  2022-09-15

4.  Admissions to intensive cardiac care units in France in 2014: A cross-sectional, nationwide population-based study.

Authors:  Grégoire Mercier; Claire Duflos; Adeline Riondel; Clément Delmas; Stéphane Manzo-Silberman; Guillaume Leurent; Meyer Elbaz; Eric Bonnefoy-Cudraz; Patrick Henry; François Roubille
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.